From memory we had preliminary results which only showed safety. We are still awaiting results on biological samples which are the only results likely to show any efficacy. These trials are fully under the control of the NIH and IVX are unlikely to be able to have any input to getting the results out. It is what happens when you accept government support for trials. One of the problems with this trial was that the FDA insist that trials must prove safety in a mild form of the disease before allowing trials in a more severe disease. It is difficult to show great efficacy in a mild form of the disease. Just a small problem along the way.
IVX Price at posting:
0.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)